Versant Ventures Launches Cimeio Therapeutics with $50 Million Series A
29.04.2022
Versant Ventures announced the debut of Cimeio Therapeutics, a biotechnology company developing a novel approach to ...
News
Ginkgo Bioworks Signs Definitive Agreement to Acquire FGen AG
18.03.2022
Ginkgo Bioworks, the leading horizontal platform for cell programming, today announced the entry into a definitive agreement to acquire...
Anaveon To Raise CHF 110 Million In Oversubscribed Series B Financing
21.12.2021
Anaveon, a clinical-stage immuno-oncology company, today announced that it has agreed a CHF 110 million Series B financing led...
Cellestia Biotech receives Orphan Drug Designation from EU Commision
16.12.2021
Cellestia Biotech AG (Cellestia) is a fully integrated R&D company specialised in the discovery and development of first-in-class...
Kinarus receives 7 Million CHF Grant
14.12.2021
Kinarus AG has been awarded a grant from the Swiss Federal Funding Programme for the development of COVID-19 Medicines...